These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 28572480)

  • 1. Herpes Zoster Vaccination Compliance: The Role of Specialist Rheumatology Nurses.
    Thakran RD; Baghel SS; Rawat R; Messi C
    J Rheumatol; 2017 Jun; 44(6):960. PubMed ID: 28572480
    [No Abstract]   [Full Text] [Related]  

  • 2. [The clinical and epidemic characteristics of shingles (herpes zoster) and its prevention with vaccines].
    Afonina NM; Mikheeva IV
    Ter Arkh; 2013; 85(11):130-3. PubMed ID: 24432613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Disseminated Varicella Zoster in Immunosuppressed Patients Receiving Zoster Vaccination.
    Bubb MR
    Mayo Clin Proc; 2015 Nov; 90(11):1585-6. PubMed ID: 26541254
    [No Abstract]   [Full Text] [Related]  

  • 4. In reply--Risk of Disseminated Varicella Zoster in Immunosuppressed Patients Receiving Zoster Vaccination.
    Cheetham TC; Sy LS; Jacobsen SJ
    Mayo Clin Proc; 2015 Nov; 90(11):1586-7. PubMed ID: 26541255
    [No Abstract]   [Full Text] [Related]  

  • 5. Herpes Zoster Vaccine: Time for a Boost?
    Reddy KP
    J Gen Intern Med; 2017 Feb; 32(2):145-147. PubMed ID: 27730484
    [No Abstract]   [Full Text] [Related]  

  • 6. Herpes Zoster Subunit Vaccination for Renal Transplant Recipients.
    Cheng MP; Quach C; Marty FM
    Clin Infect Dis; 2020 Feb; 70(4):718-719. PubMed ID: 31504313
    [No Abstract]   [Full Text] [Related]  

  • 7. Zoster vaccine in older adults.
    Fried R
    J Am Geriatr Soc; 2010 Sep; 58(9):1799-800. PubMed ID: 20863342
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk of Herpes Zoster and Disseminated Varicella Zoster in Patients Taking Immunosuppressant Drugs at the Time of Zoster Vaccination.
    Cheetham TC; Marcy SM; Tseng HF; Sy LS; Liu IL; Bixler F; Baxter R; Donahue JG; Naleway AL; Jacobsen SJ
    Mayo Clin Proc; 2015 Jul; 90(7):865-73. PubMed ID: 26051268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Q: Who should receive the shingles vaccine?
    Singh A; Englund K
    Cleve Clin J Med; 2009 Jan; 76(1):45-8. PubMed ID: 19122110
    [No Abstract]   [Full Text] [Related]  

  • 10. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine.
    Tseng HF; Lewin B; Hales CM; Sy LS; Harpaz R; Bialek S; Luo Y; Jacobsen SJ; Reddy K; Huang PY; Zhang J; Anand S; Bauer EM; Chang J; Tartof SY
    J Infect Dis; 2015 Oct; 212(8):1222-31. PubMed ID: 26038400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of non-compliance with herpes zoster vaccination in the community-dwelling elderly.
    Opstelten W; van Essen GA; Hak E
    Vaccine; 2009 Jan; 27(2):192-6. PubMed ID: 18996427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune senescence and vaccines to prevent herpes zoster in older persons.
    Levin MJ
    Curr Opin Immunol; 2012 Aug; 24(4):494-500. PubMed ID: 22857823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
    Marchetti S; Guzzetta G; Flem E; Mirinaviciute G; Scalia Tomba G; Manfredi P
    Vaccine; 2018 Feb; 36(8):1116-1125. PubMed ID: 29366704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes zoster vaccine brings relief for the elderly.
    Morrow T
    Manag Care; 2006 Dec; 15(12):57-8. PubMed ID: 17260848
    [No Abstract]   [Full Text] [Related]  

  • 15. The Herpes Zoster Vaccine in Rheumatic Diseases: Duration of Response.
    Shirley E; Chakravarty EF
    J Rheumatol; 2017 Jul; 44(7):968-969. PubMed ID: 28668813
    [No Abstract]   [Full Text] [Related]  

  • 16. [How I prevent...herpes zoster by vaccination].
    Nikkels AF; Piérard GE
    Rev Med Liege; 2007 Jan; 62(1):44-7. PubMed ID: 17343129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varicella-zoster virus vaccination under the exogenous boosting hypothesis: two ethical perspectives.
    Luyten J; Ogunjimi B; Beutels P
    Vaccine; 2014 Dec; 32(52):7175-8. PubMed ID: 25454883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes zoster vaccine live: A 10 year review of post-marketing safety experience.
    Willis ED; Woodward M; Brown E; Popmihajlov Z; Saddier P; Annunziato PW; Halsey NA; Gershon AA
    Vaccine; 2017 Dec; 35(52):7231-7239. PubMed ID: 29174682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial.
    Godeaux O; Kovac M; Shu D; Grupping K; Campora L; Douha M; Heineman TC; Lal H
    Hum Vaccin Immunother; 2017 May; 13(5):1051-1058. PubMed ID: 28068212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anterior Segment Complications Associated With the Live Herpes Zoster Vaccine.
    Kim DH
    Cornea; 2019 Feb; 38(2):e5. PubMed ID: 30431474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.